⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
prnewswire.com
ABBV
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
prnewswire.com
FMS
ABBV
JNJ
AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development
prnewswire.com
ABBV
U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
prnewswire.com
ABBV
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
Global Aptamer-Drug Conjugates Market Outlook, 2026-2032 - AI-Enabled Discovery and Precision Delivery Drive Growth Toward USD 2.14 Billion at a 15.79% CAGR
globenewswire.com
ABBV
ADCT
AZN
BMY
GSK
MRK
PFE
ROG
TAK
ZYME
UChicago Medicine finaliza la fase de construcción del Pabellón Oncológico de la Fundación AbbVie, acercando a la realidad una nueva era en la atención del cáncer
prnewswire.com
ABBV
Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off
globenewswire.com
AGCO
ANSC
ABBV
WBD
UNH
SCHW
FDX
AMZN
ZS
BNY
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
globenewswire.com
ABBV
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR